U.K. medical practice mistakenly texts patients they have “aggressive lung cancer” instead of wishing them a merry Christmas

A medical practice in England intended to text its patients wishes for a “very merry Christmas.” Instead, the mass text told patients they had “aggressive lung cancer” that had spread and asked them to fill out a form for terminal patients.  Exterior photo of England’s Askern Medical Practice. Askern Medical Practice via Facebook The mass … Read more

Retired Northwestern Medicine nurse first-ever lung, liver transplant from hospital group

CHICAGO (WLS) — He spent 25 years caring for hospital patients, as a nurse. Now, he’s the one receiving end, becoming the first person to receive a liver and lung transplant at Northwestern Medicine. “Don’t take life for granted,” lung-liver transplant recipient Patricio Collera said. Wise words from Collera, who now has a new outlook … Read more

US lung cancer survival rate rises 21%, report says, but much work remains

CNN — The five-year lung cancer survival rate has increased 21%, from 21% in 2014 to 25% in 2018, making what experts call “remarkable progress” – but it is still the leading cause of cancer death in the United States. However, in communities of color, a person’s odds of surviving five years after diagnosis are … Read more

Optimizing Treatment for Inoperable Lung Cancer

By Carl Gay, MD, PhD, as told to Hallie Levine When patients hear the term “inoperable lung cancer,” they often think that that means their cancer is incurable. But thanks to advances in treatment over the last several years, this diagnosis doesn’t mean a death sentence. There are many treatments available to slow its spread, … Read more

Ukrainian doctors train in the U.S. on how to perform heart and lung transplants : NPR

Dr. Serguei Melnitchouk (center) of Massachusetts General Hospital is training Ukrainian surgeons Volodymyr Voitko (left) and Vitalii Sokolov (right) on how to perform heart and lung transplants so they can do them in their home country. Photo taken Nov. 17, 2022, at MGH. Daniel Ackerman/Daniel Ackerman hide caption toggle caption Daniel Ackerman/Daniel Ackerman Dr. Serguei … Read more

Relief reports stability data on new formulation of lung disease drug RLF-100

gorodenkoff Relief Therapeutics (OTCQB:RLFTF)(OTCQB:RLFTD) reported six-month stability data on a new formulation of potential lung disease therapy RLF-100 (aviptadil). The company said the data showed high purity levels at six months at all temperatures tested, including at refrigerated and room temperature scenarios. The results were consistent with those seen at the three-month time period and … Read more